About: MAIA Biotechnology, Inc., together with its subsidiaries, a clinical-stage biopharmaceutical company, engages in the development of targeted immunotherapies for cancer. Its lead product Ateganosine, a telomere-targeting agent currently in clinical development to evaluate its activity in Non-Small Cell Lung Cancer (NSCLC). The company was incorporated in 2018 and is headquartered in Chicago, Illinois.
Sector: Healthcare
Industry: Biotechnology
Latest price: $1.29 (+0.39%)
Status: deslistada — removed_from_provider. Este ativo não é mais negociado; são exibidos dados históricos.
MAIA NYSE MAIA Biotechnology Inc.
MAIA Biotechnology Inc. share price
Atividade de preço de MAIA
Último preço
Variação (24h)
USD
Volume
-
Volume (média 4 sem.)
-
Fechamento anterior
N/D
Último negócio
MAIA price performance
quote.marketSignals